Two directors of Square Pharmaceuticals have completed share purchases totaling Tk 64.58 crore, according to disclosures posted on the Dhaka Stock Exchange (DSE) today.
Samuel S. Chowdhury, one of the directors, acquired 1.5 million shares from the market, as per a prior announcement made on March 10. Based on Thursday’s closing price of Tk 215.40 per share, the total purchase value is estimated at Tk 32.29 crore.
In a separate disclosure, Ratna Patra, another director, also purchased 1.5 million shares following her declaration on March 12. Her transaction is similarly valued at Tk 32.29 crore, based on the same closing price.
Shares of Square Pharmaceuticals rose by 0.05 percent to Tk 215.40 during morning trading at the DSE today.
As of March 31, 2025, the company’s sponsor-directors collectively own 43.44 percent of its shares, according to DSE data. Institutional investors hold 13.76 percent, foreign investors 15.35 percent, and the general public owns 27.45 percent.
Founded in 1958 and listed on the stock exchanges in 1995, Square Pharmaceuticals is the largest pharmaceutical company in Bangladesh. It has maintained its leadership in the sector since 1985, according to its website. With a growing presence both domestically and internationally, Square continues to be a significant contributor to the country’s pharmaceutical exports and healthcare supply chain.
 today.){kind=link}